secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2026-10-06T20:30:58+00:00
Accession:  0000947871-26-000922
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4.1-flash:cloud@v2

Quest Diagnostics EVP Catherine Doherty to retire July 2027, shifts to new EVP role Nov 1, 2026
--------------------------------------------------------------------------------

- Catherine T. Doherty will retire in July 2027; effective November 1, 2026 she moves to Executive Vice President covering health systems, the Corewell Health joint venture, and Project Nova.
- Base salary unchanged at $650,000; annual incentive target stays at 80% of base salary under the Senior Management Incentive Plan.
- Committee approved an equity award with a November 3, 2026 grant date and $1,200,000 target value, allocated 100% to restricted stock units.
- The equity award carries terms substantially the same as 2026 annual long-term incentive awards granted to other Quest senior executives.
- Project Nova is described as the company's multi-year effort to modernize its 'Order to Cash' business processes, related IT infrastructure and enabling technologies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000094787126000922/0000947871-26-000922-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000094787126000922/ss6908054_8k.htm
  HTML page:      https://secwatch.observer/filing/0000947871-26-000922

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer